Urology - Global Oncology Academy

1-16 of 47

What's Next for Urothelial Cancer Treatment?
What's Next for Urothelial Cancer Treatment?
Project Oncology®
What's Next for Urothelial Cancer Treatment?
Benjamin Garmezy, MD
- Benjamin Garmezy, MD
Moving Toward Biomarker-Driven Care in Bladder Cancer
Moving Toward Biomarker-Driven Care in Bladder Cancer
Project Oncology®
Moving Toward Biomarker-Driven Care in Bladder Cancer
Benjamin Garmezy, MD
- Benjamin Garmezy, MD
Optimizing Patient Selection for Perioperative Therapy in Bladder Cancer
Optimizing Patient Selection for Perioperative Therapy in Bladder Cancer
Project Oncology®
Optimizing Patient Selection for Perioperative Therapy in Bladder Cancer
Benjamin Garmezy, MD
- Benjamin Garmezy, MD
Supporting Patients Throughout Urothelial Carcinoma Treatment
Supporting Patients Throughout Urothelial Carcinoma Treatment
Project Oncology®
Supporting Patients Throughout Urothelial Carcinoma Treatment
Petros Grivas, MD, PhD
- Petros Grivas, MD, PhD
What’s Behind the Toxicity? Key Clues in Urothelial Carcinoma
What’s Behind the Toxicity? Key Clues in Urothelial Carcinoma
Project Oncology®
What’s Behind the Toxicity? Key Clues in Urothelial Carcinoma
Petros Grivas, MD, PhD
- Petros Grivas, MD, PhD
Monitoring Toxicities During Advanced Urothelial Carcinoma Treatment
Monitoring Toxicities During Advanced Urothelial Carcinoma Treatment
Project Oncology®
Monitoring Toxicities During Advanced Urothelial Carcinoma Treatment
Petros Grivas, MD, PhD
- Petros Grivas, MD, PhD
Advanced Urothelial Carcinoma: Optimizing Second-Line Care
Advanced Urothelial Carcinoma: Optimizing Second-Line Care
Project Oncology®
Advanced Urothelial Carcinoma: Optimizing Second-Line Care
Guru P. Sonpavde, MD
- Guru P. Sonpavde, MD
First-Line Treatment Considerations in Advanced Urothelial Carcinoma
First-Line Treatment Considerations in Advanced Urothelial Carcinoma
Project Oncology®
First-Line Treatment Considerations in Advanced Urothelial Carcinoma
Guru P. Sonpavde, MD
- Guru P. Sonpavde, MD
Current Approaches to Advanced Urothelial Carcinoma
Current Approaches to Advanced Urothelial Carcinoma
Project Oncology®
Current Approaches to Advanced Urothelial Carcinoma
Guru P. Sonpavde, MD
- Guru P. Sonpavde, MD
The Art of Treatment Sequencing in Advanced Urothelial Carcinoma
The Art of Treatment Sequencing in Advanced Urothelial Carcinoma
Project Oncology®
The Art of Treatment Sequencing in Advanced Urothelial Carcinoma
Guru P. Sonpavde, MD
- Guru P. Sonpavde, MD
Can AI Imaging Improve Risk Stratification in Upper Tract Urothelial Carcinoma?
Can AI Imaging Improve Risk Stratification in Upper Tract Urothelial Carcinoma?
Project Oncology®
Can AI Imaging Improve Risk Stratification in Upper Tract Urothelial Carcinoma?
Urine RNA Panel Supports Less Invasive Bladder Cancer Surveillance
Urine RNA Panel Supports Less Invasive Bladder Cancer Surveillance
Project Oncology®
Urine RNA Panel Supports Less Invasive Bladder Cancer Surveillance
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Project Oncology®
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Charles Turck, PharmD, BCPS, BCCCP; Petros Grivas, MD, PhD
- Charles Turck, PharmD, BCPS, BCCCP
- Petros Grivas, MD, PhD
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Project Oncology®
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Charles Turck, PharmD, BCPS, BCCCP; Guru P. Sonpavde, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Guru P. Sonpavde, MD
Redefining First-Line Therapy in mCSPC: Applying Evidence in Practice
Redefining First-Line Therapy in mCSPC: Applying Evidence in Practice
Project Oncology®
Redefining First-Line Therapy in mCSPC: Applying Evidence in Practice
Brian P. McDonough, MD, FAAFP; William Oh, MD
- Brian P. McDonough, MD, FAAFP
- William Oh, MD
ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
Project Oncology®
ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
Charles Turck, PharmD, BCPS, BCCCP; Pooja Ghatalia, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Pooja Ghatalia, MD

Prev
1
2
3
Next

1/3